We are live on
!
Find out more
ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Est. Return
7.38%
This Fund
S&P 500
This Quarter
Est. Return
+11.25%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$69M
(+29%)
Cap. Flow
+$46.5M
Cap. Flow
% of AUM
14.94%
Top 10 Holdings %
Top 10 Hldgs %
34.58%
Holding
105
New
32
Increased
29
Reduced
26
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Universal Health Services
UHS
|
+$11.2M |
| 2 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
+$7.93M |
| 3 |
VWR
VWR Corporation
VWR
|
+$6.84M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$6.5M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
+$5.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$9.69M |
| 2 |
Encompass Health
EHC
|
+$5.34M |
| 3 |
SHPG
Shire pic
SHPG
|
+$4.9M |
| 4 |
McKesson
MCK
|
+$4.57M |
| 5 |
HOLX
Hologic
HOLX
|
+$3.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 86.32% |
| 2 | Financials | 3.19% |
| 3 | Industrials | 2.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Abbott
ABT
$183B
| $13.8M | 4.42% |
309,740
+77,291
| +33% | +$3.34M |
|
2
Becton Dickinson
BDX
$45.6B
| $12.9M | 4.14% |
71,956
+23,781
| +49% | +$4.15M |
|
|
3
Universal Health Services
UHS
$10.2B
| $11.8M | 3.81% |
+95,100
| New | +$11.2M |
|
|
SHPG
4
DELISTED
Shire pic
SHPG
| $11.5M | 3.7% |
66,096
-28,050
| -30% | -$4.9M |
|
5
DaVita
DVA
$15.4B
| $10.8M | 3.46% |
158,479
+74,440
| +89% | +$4.93M |
|
|
AET
6
DELISTED
Aetna Inc
AET
| $9.93M | 3.19% |
77,827
+35,984
| +86% | +$4.52M |
|
7
UnitedHealth
UNH
$376B
| $9.88M | 3.18% |
60,256
+7,100
| +13% | +$1.16M |
|
8
Elevance Health
ELV
$81.5B
| $9.28M | 2.98% |
56,098
+27,998
| +100% | +$4.45M |
|
|
9
Jazz Pharmaceuticals
JAZZ
$15.9B
| $8.87M | 2.85% |
61,100
+44,700
| +273% | +$5.82M |
|
|
OXFD
10
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $8.84M | 2.84% |
570,971
+554,915
| +3,456% | +$7.93M |
|
|
CTLT
11
DELISTED
CATALENT, INC.
CTLT
| $8.25M | 2.65% |
291,308
+232,300
| +394% | +$6.5M |
|
|
ESRX
12
DELISTED
Express Scripts Holding Company
ESRX
| $7.78M | 2.5% |
118,027
+21,900
| +23% | +$1.51M |
|
13
Cardinal Health
CAH
$53.9B
| $7.61M | 2.45% |
93,291
+44,191
| +90% | +$3.48M |
|
14
Pfizer
PFE
$143B
| $7.54M | 2.43% |
232,407
+85,796
| +59% | +$2.71M |
|
|
VWR
15
DELISTED
VWR Corporation
VWR
| $7.23M | 2.33% |
+256,484
| New | +$6.84M |
|
|
CELG
16
DELISTED
Celgene Corp
CELG
| $7.16M | 2.3% |
57,500
+22,020
| +62% | +$2.64M |
|
|
AGN
17
DELISTED
Allergan plc
AGN
| $6.55M | 2.11% |
27,416
-9,300
| -25% | -$2.17M |
|
|
WBA
18
DELISTED
Walgreens Boots Alliance
WBA
| $6.3M | 2.03% |
75,864
-4,100
| -5% | -$344K |
|
19
Cencora
COR
$60.6B
| $6.17M | 1.98% |
69,740
-13,800
| -17% | -$1.21M |
|
20
Thermo Fisher Scientific
TMO
$213B
| $5.94M | 1.91% |
38,686
+2,200
| +6% | +$336K |
|
21
Boston Scientific
BSX
$69.5B
| $5.63M | 1.81% |
226,198
-106,000
| -32% | -$2.58M |
|
22
GSK
GSK
$104B
| $5.55M | 1.79% |
105,360
+36,240
| +52% | +$1.84M |
|
23
Stryker
SYK
$125B
| $5.41M | 1.74% |
41,063
-17,752
| -30% | -$2.24M |
|
|
HRC
24
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $5.2M | 1.67% |
73,619
-37,716
| -34% | -$2.4M |
|
|
HOLX
25
DELISTED
Hologic
HOLX
| $5.09M | 1.64% |
119,558
-80,400
| -40% | -$3.28M |
|
Similar funds
VAFP
CA
SCM
FWM
TOPU
CCMU
TGI
HSCU
Endurant Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Endurant Capital Management held 105 positions worth $311M, up 29% from $242M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Endurant Capital Management deployed $46.5M of net new capital in Q1 2017, opening 32 new positions and adding to 29 existing holdings. Its largest new stake was Universal Health Services: 95,100 shares worth $11.8M.
By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 88% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Encompass Health, an estimated $5.34M trimmed.
- Endurant Capital Management's largest Q1 2017 buy was Universal Health Services: 95,100 shares worth $11.8M.
- Endurant Capital Management added most to Oxford Immunotec Global PLC Ordinary Shares in Q1 2017, an estimated $7.93M increase.
- Endurant Capital Management's biggest Q1 2017 reduction was Encompass Health, cutting an estimated $5.34M.
- Endurant Capital Management fully exited St Jude Medical in Q1 2017, selling an estimated $9.69M.
- Endurant Capital Management's ten largest holdings make up 35% of its $311M portfolio in Q1 2017.
- Endurant Capital Management opened 32 new positions and closed 17 in Q1 2017.
- Endurant Capital Management's portfolio value rose 29% quarter-over-quarter to $311M.
Based on Endurant Capital Management's 13F filing for Q1 2017, filed 15 May 2017.